Cite
MLA Citation
Kunal Patel et al.. “NIMG-54. DIFFUSION MRI PHENOTYPES PREDICT OVERALL SURVIVAL BENEFIT FROM BEVACIZUMAB IN RECURRENT GLIOBLASTOMA WITH A LARGE TUMOR BURDEN: EVIDENCE FROM CLINICAL PRACTICE AND A MULTICENTER PHASE 3 TRIAL.” Neuro-oncology, vol. 21, n.d., p. vi173. http://access.bl.uk/ark:/81055/vdc_100094880467.0x00004f